For example, the expression of ΔNp63 was suppressed by TRPS1-CHD4/NuRD(MTA2), which decommissioned TP63 enhancer leading to reduced metastatic ability of breast cancer cells and better survival of breast cancer patients. This evidence concerns the gene MTA2 and breast carcinoma.